Santa Clara, CAA growing number of lawsuits alleging that popular diabetes and weight-loss drugs caused sudden vision loss known as non-arteritic anterior ischemic optic neuropathy (NAION), are now moving forward in coordinated... Read more »
Santa Clara, CAAt least 70 complaints have been filed against Ozempic, Wegovy, Saxenda, and Trulicity claiming that GLP-1 receptor agonists triggered irreversible eye damage called non-arteritic anterior ischemic optic neuropathy (NAION). Legal... Read more »
Philadelphia, PAIn February, the rapidly growing number of Ozempic side effect lawsuits was consolidated for pre-trial proceedings in the Eastern District of Pennsylvania. Multidistrict Litigation (MDL) 3094 was stalled at first, but... Read more »